APTEVO THERAPEUTICS INC (APVO:NASDAQ)

$1.79 -0.01 (-0.5556%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 84

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed APTEVO THERAPEUTICS INC (APVO:NASDAQ) News Sources

Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer

28-05-2026

yahoo.com

APVO: Initiating Coverage of Aptevo Therapeutics Inc.; Unlocking the Next Generation of Multispecific Immune Engagement

16-06-2026

yahoo.com

Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trispecific Immunotherapy for Solid Tumors

30-06-2026

yahoo.com

Aptevo Strengthens Solid Tumor Strategy with Patent Filing for Nectin-4 x PD-L1 Dual Targeting Backbone

27-07-2026

yahoo.com

Aptevo Therapeutics Announces Exercise of Existing Warrants and PIPE for $4.5 Million Gross Proceeds

12-08-2026

yahoo.com

Aptevo Provides 2Q26 Business Update and Reports Second Quarter Financial Results

14-08-2026

yahoo.com

APVO: Focusing on Three Key Areas of Development

24-08-2026

yahoo.com

Aptevo Reports 93% Clinical Benefit Rate with Mipletamig Triplet in Difficult-to-Treat TP53-Mutated Frontline AML

03-09-2026

yahoo.com

Aptevo Reports 93% Clinical Benefit Rate for Mipletamig Triplet in TP53-Mutated AML

03-09-2026

advfn.com

Aptevo Advances Next-Generation Trispecific Candidate Toward Clinical Development

24-09-2026

yahoo.com

APTEVO THERAPEUTICS INC (APVO:NASDAQ) Sentiment Trend

0 25 50 75 100 84 91 89 86 74 72 89 81 86 89 28-05-2026 16-06-2026 30-06-2026 27-07-2026 12-08-2026 14-08-2026 24-08-2026 03-09-2026 24-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

APTEVO THERAPEUTICS INC (APVO:NASDAQ) FAQs

toggle

What is the current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The current price of APTEVO THERAPEUTICS INC (APVO:NASDAQ) is $1.79.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) absolute price change since previous trading day?

The absolute price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is $-0.01.


toggle

APTEVO THERAPEUTICS INC (APVO:NASDAQ) percentage price change since previous trading day?

The percentage price change of APTEVO THERAPEUTICS INC (APVO:NASDAQ) since the previous trading day is -0.5556%.


toggle

What is the most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent average sentiment score for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is 84 out of 100.


toggle

What is the most recent average sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ)?

The most recent sentiment for APTEVO THERAPEUTICS INC (APVO:NASDAQ) is .


SEC-8K** Filing Available For APTEVO THERAPEUTICS INC (APVO:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.